The incidence, risk factors and prognostic implications of venous thromboembolism in patients with gastric cancer

Journal of Thrombosis and Haemostasis

Volumn 8, Issue 3, 2010, Pages 540-547

  Lee, K W ^a   Bang, S M ^a   Kim, S ^a   Lee, H J ^a   Shin, D Y ^a   Koh, Y ^a   Lee, Y G ^a   Cha, Y ^a   Kim, Y J ^a   Kim, J H ^a   Park, D J ^a   Kim, H H ^a   Oh, D ^b   Lee, J S ^a  

^a Seoul National University Bundang Hospital   (South Korea)

^b CHA University   (South Korea)

Author keywords

Gastric cancer; Thrombosis; Venous thromboembolism

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGE; AGED; ARTICLE; ASIAN; CANCER PALLIATIVE THERAPY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DEATH; ENDOSCOPIC SURGERY; FEMALE; GASTRECTOMY; HUMAN; INCIDENCE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR; STOMACH CANCER; TOTAL STOMACH RESECTION; VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM;

ABDOMEN; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; DATABASES AS TOPIC; EXTREMITIES; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INCIDENCE; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PULMONARY EMBOLISM; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STOMACH NEOPLASMS; SURGICAL PROCEDURES, OPERATIVE; TIME FACTORS; VENOUS THROMBOEMBOLISM; YOUNG ADULT;

EID: 77949283143     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2009.03731.x     Document Type: Article

References (20)

1. Lyman GH, Khorana AA, Falanga A, Clarke-Pearson D, Flowers C, Jahanzeb M, Kakkar A, Kuderer NM, Levine MN, Liebman H, Mendelson D, Raskob G, Somerfield MR, Thodiyil P, Trent D, Francis CW. American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. J Clin Oncol 2007, 25:5490-505.
2. Chew HK, Wun T, Harvey D, Zhou H, White RH. Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch Intern Med 2006, 166:458-64.
3. Tetzlaff ED, Correa AM, Baker J, Ensor J, Ajani JA. The impact on survival of thromboembolic phenomena occurring before and during protocol chemotherapy in patients with advanced gastroesophageal adenocarcinoma. Cancer 2007, 109:1989-95.
4. Alcalay A, Wun T, Khatri V, Chew HK, Harvey D, Zhou H, White RH. Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival. J Clin Oncol 2006, 24:1112-8.
5. Chew HK, Wun T, Harvey DJ, Zhou H, White RH. Incidence of venous thromboembolism and the impact on survival in breast cancer patients. J Clin Oncol 2007, 25:70-6.
6. Oh SY, Kim JH, Lee KW, Bang SM, Hwang JH, Oh D, Lee JS. Venous thromboembolism in patients with pancreatic adenocarcinoma: lower incidence in Asian ethnicity. Thromb Res 2008, 122:485-90.
7. Shin HR, Jung KW, Won YJ, Park JG. Annual report of the Korea Central Cancer Registry: based on registered data from 139 Hospitals. Cancer Res Treat 2004, 36:103-14.
8. Lee SI, Choi YS, Park DJ, Kim HH, Yang HK, Kim MC. Comparative study of laparoscopy-assisted distal gastrectomy and open distal gastrectomy. J Am Coll Surg 2006, 202:874-80.
9. Hwang SH, Park do J, Jee YS, Kim HH, Lee HJ, Yang HK, Lee KU. Risk factors for operative complications in elderly patients during laparoscopy-assisted gastrectomy. J Am Coll Surg 2009, 208:186-92.
10. Ohtsu A, Yoshida S, Saijo N. Disparities in gastric cancer chemotherapy between the East and West. J Clin Oncol 2006, 24:2188-96.
11. Park JM, Kim YH. Current approaches to gastric cancer in Korea. Gastrointest Cancer Res 2008, 2:137-44.
12. De Stefano V, Fiorini A, Rossi E, Za T, Farina G, Chiusolo P, Sica S, Leone G. Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders. J Thromb Haemost 2007, 5:708-14.
13. Janssen HL, Meinardi JR, Vleggaar FP, van Uum SH, Haagsma EB, van Der Meer FJ, van Hattum J, Chamuleau RA, Adang RP, Vandenbroucke JP, van Hoek B, Rosendaal FR. Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study. Blood 2000, 96:2364-8.
14. Primignani M, Martinelli I, Bucciarelli P, Battaglioli T, Reati R, Fabris F, Dell'era A, Pappalardo E, Mannucci PM. Risk factors for thrombophilia in extrahepatic portal vein obstruction. Hepatology 2005, 41:603-8.
15. Amitrano L, Brancaccio V, Guardascione MA, Margaglione M, Iannaccone L, Dandrea G, Ames PR, Marmo R, Mosca S, Balzano A. High prevalence of thrombophilic genotypes in patients with acute mesenteric vein thrombosis. Am J Gastroenterol 2001, 96:146-9.
16. Madonna P, De Stefano V, Coppola A, Cerbone AM, Di Minno G. G20210A prothrombin gene mutation and other trombophilic polymorphisms in patients with portal or hepatic venous thrombosis. Gastroenterology 2001, 120:1059-60.
17. Martinelli I, Franchini M, Mannucci PM. How I treat rare venous thromboses. Blood 2008, 112:4818-23.
18. Gollin G, Ward B, Meier GH, Sumpio BE, Gusberg RJ. Central splanchnic venous thrombosis. Often unsuspected, usually uncomplicated. J Clin Gastroenterol 1994, 18:109-13.
19. Sorensen HT, Mellemkjaer L, Olsen JH, Baron JA. Prognosis of cancers associated with venous thromboembolism. N Engl J Med 2000, 343:1846-50.
20. Lee AY, Levine MN. Venous thromboembolism and cancer: risks and outcomes. Circulation 2003, 107:I17-21.